Clinical Trials for Neovascular Age-Related Macular Degeneration (nAMD)
There are 4 clinical trials for Neovascular Age-Related Macular Degeneration (nAMD), with 4 actively recruiting participants. Phase breakdown: Phase 3: 2, Phase 1 / Phase 2: 1, Early Phase 1: 1. Always talk to your doctor about whether a clinical trial is right for you.
Key Data
| Metric | Value |
|---|---|
| Total Trials | 4 |
| Recruiting Now | 4 |
| Phase 3 | 2 |
| Phase 1 / Phase 2 | 1 |
| Early Phase 1 | 1 |
| Active Sponsors | 4 |
Top Sponsors
- 4D Molecular Therapeutics (1 trials)
- Alcon Research (1 trials)
- Adverum Biotechnologies, Inc. (1 trials)
- HuidaGene Therapeutics Co., Ltd. (1 trials)
Data sourced from ClinicalTrials.gov. Last updated 2026-04-06. This site does not provide medical advice.